Express Pharma

APRIL 2, 2025

healthcare by ensuring a steady supply of affordable medicines. The decision underscores the critical role of cost-effective, life-saving generic medicines in public health, economic stability, and national security. Pharmaceuticals remain a cornerstone of this partnership, as India plays a vital role in global and U.S.

Generic Medicine 94

Generic Medicine 94

Putting Patients First Blog

MAY 6, 2025

33 These partnerships provide American patients with access to a wide range of critical medicines manufactured to rigorous quality standardsmedicines that complement, rather than compete with, domestic production.

Pharmaceutical Manufacturing 52

Pharmaceutical Manufacturing Generic Medicine Drug Pricing Hospitals 52

Express Pharma

APRIL 7, 2025

This strategy has been particularly prominent in countries like India, which is one of the largest producers of generic medicines and has been a key player in the global FDC market.

Generic Medicine 66

Generic Medicine Pharmaceutical Companies Pharmaceutical Companies Diabetes 66

European Pharmaceutical Review

MAY 27, 2025

Generic medicine Emtricitabine/Tenofovir alafenamide Viatris (emtricitabine / tenofovir alafenamide), received a positive opinion to treat adults and adolescents with human immunodeficiency virus type 1 (HIV-1). Additionally, the treatment was recommended for adults and skeletally mature adolescents with giant cell tumour of bone.

Biosimilars 59

Biosimilars Generic Medicine 59

Express Pharma

MARCH 12, 2025

The FDA has an established office in India overseeing the number of qualified manufacturers supplying generic medicines to the US. The United States Food and Drug Administration (FDA) conducts rigorous inspections of both domestic and foreign manufacturing facilities, including those in India.

Generic Medicine 66

Generic Medicine Process Improvement Dosage Pharmaceutical Manufacturing 66

STAT

APRIL 23, 2025

Novartis chief executive Vas Narasimhan and Paul Hudson, his counterpart at Sanofi, say the European Commission should set a spending target for medicines and vaccines to “fairly reward innovation.”  pays nearly three times as much for branded and generic medicines as other comparable countries, according to U.S.

Compounding 216

Compounding Generic Medicine Pharmaceutical Companies Pharmaceutical Companies 216

Pharmaceutical Technology

JUNE 18, 2025

Amid President Donald Trump’s stated desire to sharply reduce drug prices on the US market, India has also proposed to supply generic medicines at between 20% and 25% of the current reference branded prices, for three years after originator patent expiry.

Drug Pricing 52

Drug Pricing Communication Pharmaceutical Companies Pharmaceutical Companies 52

PharmaTech

JUNE 30, 2025

The company has invested $4 billion in the past 15 years to expand its US operations, which began in 1991, and now has an annual domestic capacity to produce 12 billion finished doses of generic medicines. Hikma Publishes its 2024 Sustainability Report Reinforcing Commitment to Global Access to Medicines. Press Release.

Dosage 59

Dosage Drug Development Generic Medicine Vaccines 59

European Pharmaceutical Review

MAY 8, 2025

The industry group further called for the EU to: Advocate a US and EU deal for the free passage of pharmaceuticals between markets Support the Critical Medicines Act Ensure timely entry of generic medicines. There is no reason to extend exclusivity periods in Europe, there is actually a strong case to reduce.

Generic Medicine 59

Generic Medicine 59

STAT

APRIL 30, 2024

A controversial provision of a federal law designed to speed copycat drugs to market and foster competition saved Medicare Part D nearly $15 billion from 2015 to 2021 on just 15 medicines during that period, according to a new analysis.

Labelling 285

Labelling Generic Medicine Biosimilars 285

STAT

SEPTEMBER 18, 2024

patent system by the pharmaceutical industry, moves by some drugmakers to expand their patent claims appear to be delaying the arrival of lower-cost generic medicines to the marketplace, according to a STAT analysis.  Amid debate over potential abuse of the U.S.

Generic Medicine 359

Generic Medicine Drug Pricing 359

STAT

FEBRUARY 5, 2024

In one example, J&J allegedly paid its PBM more than $10,000 for a single 90-day prescription of teriflunomide, a generic medicine for multiple sclerosis, when that same 90-day prescription could be purchased for as little as $30 elsewhere without insurance, according to the lawsuit.

Generic Medicine 363

Generic Medicine 363

STAT

JANUARY 5, 2024

As a former editor for diabetes publications, I knew that insurance companies regularly switched people from one brand of insulin to another, or from a name brand of insulin to a generic. However, I had used generic medicine for my blood pressure without a problem, so I hoped for the best with this switch.

Generic Medicine 317

Generic Medicine Diabetes 317

STAT

DECEMBER 4, 2024

Specifically, the proposed rule was crafted to stem the use of so-called patent thickets , which are wielded by drug companies to delay the arrival of lower-cost generic medicines in the marketplace.

Generic Medicine 297

Generic Medicine Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 297

STAT

SEPTEMBER 19, 2024

Amid ongoing concern over the quality of medicines made in India, a major supplier of generic medicines was seen removing three truckloads of “scrap materials” from a facility that was being inspected last month by the Food and Drug Administration.

Documentation 297

Documentation Generic Medicine 297

STAT

JUNE 17, 2024

Patent and Trademark Office has proposed a new rule designed to stem the use of so-called patent thickets , which are wielded by pharmaceutical companies to delay the arrival of lower-cost generic medicines in the marketplace.

Generic Medicine 321

Generic Medicine Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 321

STAT

SEPTEMBER 14, 2023

In explaining its new policy statement , the FTC noted that some drug companies have failed to follow requirements for listing patents in the so-called Orange Book in hopes of thwarting competition from lower-cost generic medicines.

Generic Medicine 328

Generic Medicine Pharmaceutical Companies Pharmaceutical Companies 328

STAT

SEPTEMBER 29, 2023

A handful of the largest purveyors of generic medicines have made only halting progress to ensure their drugs are accessible for patients in low- and middle-income countries, a new analysis found.

Generic Medicine 291

Generic Medicine 291

STAT

MARCH 1, 2024

A growing number of alternative pharmacies — such as those run by Costco, Amazon, and Mark Cuban Cost Plus Drugs — may be increasingly popular with American consumers, but a new analysis finds many of the most expensive generic medicines are unavailable, prices vary widely, and savings can be modest.

Generic Medicine 321

Generic Medicine 321

STAT

NOVEMBER 7, 2023

The move comes two months after the FTC issued a policy statement noting some drug companies have failed to follow requirements for listing patents in the Food and Drug Administration’s Orange Book in hopes of thwarting competition from lower-cost generic medicines. Continue to STAT+ to read the full story…

Generic Medicine 315

Generic Medicine 315

European Pharmaceutical Review

FEBRUARY 20, 2025

For instance, in the EU, 46 percent of generic medicines from the EU Critical List of Medicines are provided by a single supplier. For these firms with over 60 percent market share, this number rises to 83 percent of critical generic medicines, according to the data.

Generic Medicine 59

Generic Medicine 59

STAT

NOVEMBER 3, 2022

A leaked draft version of a trade agreement being negotiated between the United Kingdom and India has sparked concern among civil society and patient advocacy groups that the proposed deal would impede the supply of affordable generic medicines in poor countries around the world.

Generic Medicine 255

Generic Medicine Drug Development 255

STAT

MARCH 21, 2023

A leaked version of the agreement already sparked concerns last year that the proposed deal would impede the supply of affordable generic medicines in poor countries around the world. More than 200 civil society and patient advocacy groups are urging the U.K. Now, the groups are upset that the involvement of Harjinder Kang, the U.K.

Generic Medicine 255

Generic Medicine Pharmaceutical Companies Pharmaceutical Companies 255

STAT

FEBRUARY 10, 2023

WASHINGTON — Generic drugmakers lobbied hard against Democrats’ new law empowering Medicare to negotiate prescription drug prices. Giving the government such power seemed like an admission that generic medicines don’t do enough to keep costs down.

Drug Pricing 246

Drug Pricing Generic Medicine Packaging 246

STAT

MAY 23, 2023

But it’s a generic medicine — which means PBMs’ negotiating techniques don’t apply. Generic drugs compete on price. There’s just one problem: PBMs don’t have anything to do with that discrepancy. The chemo drug in question, Imatinib, costs $17,000 at CVS and just $72 at Cost Plus Drugs.

Generic Medicine 246

Generic Medicine Drug Pricing 246

STAT

JULY 21, 2023

The review comes in response to an inspection of Synapse facilities by Spanish regulators, who raised “serious concerns about the validity and reliability” of clinical trial data generated by the company.

Generic Medicine 246

Generic Medicine 246

PharmaState Academy

SEPTEMBER 28, 2023

The conversation led by Gauri Chaudhari ended with Gauri Chaudhari saying it should be ‘BRANDED & GENERIC MEDICINES’. The major issues involved in the NMC decision is the price of branded medicines. In the first place are our branded generic medicines really expensive? I fully agree with her.

Generic Medicine 52

Generic Medicine 52

pharmaphorum

FEBRUARY 15, 2024

The FTC is investigating wholesalers and other middlemen in the pharma supply chain to assess their possible role in worsening shortages of generic medicines

Generic Medicine 113

Generic Medicine 113

The Guardian - Pharmaceutical Industry

JANUARY 22, 2024

Roared on by the pharmaceutical industry, ministers have been using trade talks with India to push for agreement on new, extremely restrictive patent rules that would severely undermine its generic medicines industry.

Generic Medicine 107

Generic Medicine 107

Drug Channels

SEPTEMBER 10, 2020

George examines the economic impact of generic pharmaceuticals on the U.S. He argues that the generics industry provides safe, effective, and affordable medicines for many Americans. Today’s guest post comes from George Keefe, Senior Vice President of External Affairs and Public Policy at Teva Pharmaceuticals.

Generic Medicine 52

Generic Medicine 52

Express Pharma

JANUARY 7, 2025

Goldman Sachs Asset Management, to acquire a majority stake in Synthon International Holdings BV, a company engaged in developing, manufacturing, and out-licensing complex generic medicines, for a consideration of approximately $2.1 billion; AlpInvest Partners B.V. and Sixth Street Specialty Lending, investing $945.6 million.

Generic Medicine 105

Generic Medicine 105

Express Pharma

APRIL 4, 2024

Zena Health plans to strengthen its reach and democratise healthcare in Eastern India Zeno Health, omni channel platform for quality and affordable generic medicines has announced its acquisition of Kolkata-based startup Tablt Pharmacy.

Generic Medicine 104

Generic Medicine Online Pharmacies 104

pharmaphorum

JUNE 19, 2024

Amazon Pharmacy is expanding its subscription service for generic medicines, making it available to Medicare patients

Generic Medicine 69

Generic Medicine 69

Pharma Pathway

JANUARY 29, 2023

-Walk-In Interview for Quality Control On 1st Feb’ 2023 Job Description Felix Generics Pvt. is a pharmaceutical generics business Company. HPRA Approved (April 2021) facility for veterinary generic medicines. Parent entity based in Ireland. Manufacturing facility based at SEZ Pithampur , Indore.

Generic Medicine 84

Generic Medicine 84

Express Pharma

MAY 3, 2023

We are committed to maintaining strict adherence to the highest quality standards and to ensuring delivery of safe and effective generic medicines to our patients in the US and around the world.” ” The post Indoco receives EIR for its manufacturing facility in Goa (Plant I) appeared first on Express Pharma.

Dosage 97

Dosage Generic Medicine 97

The Guardian - Pharmaceutical Industry

AUGUST 15, 2023

Indian Medical Association says that testing is substandard in the manufacture of generic medicines with ‘no guarantee of quality’ Indian doctors have been told they can no longer prescribe branded drugs for their patients, provoking vehement protest from the Indian Medical Association [IMA].

Generic Medicine 75

Generic Medicine 75

Pharmaceutical Technology

DECEMBER 15, 2022

Europe also enforces rigid pricing policies for essential medicines to be available at the lowest possible price. These factors combined affect the commercial viability of generic medicines, with some European drugmakers already warning that they may stop making cheap generic medicines.

Generic Medicine 98

Generic Medicine Drug Pricing Biosimilars Hospitals 98